Probing R-parity violating models of neutrino mass at the LHC via top squark decays

It is shown that the R-parity violating decays of the lighter top squarks (${\widetilde t}_1$) triggered by the lepton number violating couplings $\lambda^{\prime}_{i33}$, where the lepton family index i = 1-3, can be observed at the LHC via the dilepton di-jet channel even if the coupling is as small as 10$^{-4}$ or 10$^{-5}$, which is the case in several models of neutrino mass, provided it is the next lightest supersymmetric particle(NLSP) the lightest neutralino being the lightest supersymmetric particle(LSP). We have first obtained a fairly model independent estimate of the minimum observable value of the parameter ($P_{ij} \equiv BR(\widetilde t \to l_i^+ b) \times BR(\widetilde t^* \to l_j^- \bar b$)) at the LHC for an integrated luminosity of 10fb$^{-1}$ as a function of \mlstop by a standard Pythia based analysis. We have then computed the parameter $P_{ij}$ in several representative models of neutrino mass constrained by the neutrino oscillation data and have found that the theoretical predictions are above the estimated minimum observable levels for a wide region of the parameter space.Comment: 19 pages, 1 Figure and 11 Table

New signals of a R-parity violating model of neutrino mass at the Tevatron

In a variety models of neutrino masses and mixings the lighter top squark decays into competing R - parity violating and R - parity conserving channels. Using Pythia we have estimated in a model independent way the minimum value of P $\equiv$ BR($\widetilde t_1 \to c \widetilde \chi_1^0$) $\times$ BR($\widetilde t_1 \to l^+_i b$), where $l_i = e^+$ and $\mu^+$, corresponding to an observable signal involving the final state 1$l$ + jets +\met (carried by the neutrinos from the $\tilde \chi_1^0$ decay) at Tevatron Run II. For the kinematical cuts designed in this paper P depends on $m_{\widetilde t_1}$ only. We then compute P for representative choices of the model parameters constrained by the oscillation data and find that over a significant region of the allowed parameter space P is indeed larger than $P_{min}$. This signal is complementary to the dilepton + dijet signal studied in several earlier experimental and phenomenological analyses and may be observed even if BR($\widetilde t_1 \to l^+_i b$) is an order of magnitude smaller than BR($\widetilde t_1 \to c \widetilde \chi_1^0$). The invariant mass distribution of the hardest lepton and the hardest jet may determine $m_{\widetilde t_1}$ and reveal the lepton number violating nature of the underlying interaction. The invariant mass distribution of the two lowest energy jets may determine $m_{\widetilde \chi_1^0}$.Comment: Some minor changes in language are made at pages 1,2,8 and 18 respectivel

Top squark and neutralino decays in a R-parity violating model constrained by neutrino oscillation data

In a R-parity violating (RPV) model of neutrino mass with three bilinear couplings $\mu_i$ and three trilinear couplings $\lambda'_{i33}$, where $i$ is the lepton index, we find six generic scenarios each with a distinctive pattern of the trilinear couplings consistent with the oscillation data. These patterns may be reflected in direct RPV decays of the lighter top squark or in the RPV decays of the lightest superparticle, assumed to be the lightest neutralino. Typical signal sizes at the Tevatron RUN II and the LHC have been estimated and the results turn out to be encouraging.Comment: 20 pages, 4 figures, LaTex,typos corrected and reference added for section 2, a paragraph has been added in the conclusion par

A prospective open-label randomized comparative study in Alzheimer’s disease between two commonly used drugs in coastal Indian population

Background: Currently, therapy for Alzheimer’s disease (AD) is only symptomatic. Only two classes of drugs are approved by the United States Food and Drug Administration. Our study aimed at comparing efficacy and safety of memantine and donepezil in moderate to severe AD patients.Methods: Totally, 22 patients with moderate to severe AD were randomized into the 2 arms of the study. The study was divided into an initial 4 weeks for determination of onset of efficacy and subsequent 28 weeks of the treatment phase. Onset of efficacy and response was defined as >20% and >50% reduction in the mean total score of functional dementia scale (FDS) and clinical global impression scale (CGIS) from baseline to the study end, respectively.Results: Onset of efficacy on FDS and CGIS was 16.7% (mean-time 61.25 days) and 80% (mean-time 36 days) with memantine and donepezil, respectively. Response was 89.3% and 40% with memantine and Donepezil, respectively. Total reduction in FDS and CGIS score of from baseline to the study end was 39.50, 40.00, and 25.60, 27.20 with memantine and donepezil, respectively. Tolerability was 86.33% and 20% with memantine and donepezil, respectively. Anorexia, muscle cramps, constipation, headache, and insomnia, were the common side-effects and self-limiting. Safety was 100% in both groups.Conclusions: Onset of efficacy was faster with donepezil seen at 2 weeks. Response, improvement in CGIS, FDS, and tolerability were better seen with memantine at 40 weeks. Thus, in similar clinical settings, memantine can be preferred

Xylazine in the Opioid Epidemic: A Systematic Review of Case Reports and Clinical Implications

Introduction and objectives: The opioid overdose epidemic is exacerbated by the emergence of Xylazine as an illicit drug adulterant. Xylazine, a veterinary sedative, can potentiate opioid effects while also causing toxic and potentially fatal side effects. This systematic review aims to assess the impact of Xylazine use and overdoses within the opioid epidemic context.Method: A systematic search was conducted following PRISMA guidelines to identify relevant case reports, and case series related to Xylazine use. A comprehensive literature search included databases like Web of Science, PubMed, Embase, and Google Scholar, utilizing keywords and Medical Subject Headings (MeSH) terms related to Xylazine. Thirty-four articles met the inclusion criteria for this review. Results: Intravenous (IV) administration was a common route for Xylazine use among various methods, including subcutaneous (SC), intramuscular (IM), and inhalation, with overall doses ranging from 40 mg to 4300 mg. The average dose in fatal cases was 1,200 mg, compared to 525 mg in non-fatal cases. Concurrent administration of other drugs, primarily opioids, occurred in 28 cases (47.5%). Intoxication was identified as a notable concern in 32 out of 34 studies, and treatments varied, with the majority experiencing positive outcomes. Withdrawal symptoms were documented in one case study, but the low number of cases with withdrawal symptoms may be attributed to factors such as a limited number of cases or individual variation. Naloxone was administered in eight cases (13.6%), and all patients recovered, although it should not be misconstrued as an antidote for Xylazine intoxication. Of the 59 cases, 21 (35.6%) resulted in fatal outcomes, with 17 involving Xylazine use in conjunction with other drugs. The IV route was a common factor in six out of the 21 fatal cases (28.6%). Conclusion: This review highlights the clinical challenges associated with Xylazine use and its co-administration with other substances, particularly opioids. Intoxication was identified as a major concern, and treatments varied across the studies, including supportive care, naloxone, and other medications. Further research is needed to explore the epidemiology and clinical implications of Xylazine use. Understanding the motivations and circumstances leading to Xylazine use, as well as its effects on users, is essential for developing effective psychosocial support and treatment interventions to address this public health crisis

Vortex fluctuations in superconducting La-Sr-Cu-O

Vortex fluctuations in the $La_{2-x}Sr_{x}CuO_{4+\delta}$ system have been studied as a function of magnetic field, temperature and carrier concentration in order to determine the dimensionality of the fluctuations. For a $x=0.10$ sample, there is a unique crossing-temperature on the magnetization vs. temperature plots for all magnetic fields up to 7 T, and the data scale very well with 2D fluctuation theory. At lower x-values where $H_{c2}$ is much smaller, there are two well defined crossing points, one at low fields (typically less than 1 T) and another at high fields (typically 3-7 T). A fit of the data to fluctuation theory shows that the low field crossing data scale as 2D fluctuations and the high field crossing data scale as 3D fluctuations. It would appear that as the magnetic field approaches $H_{c2}$, there is a 2D to 3D cross-over where the low field 2D pancake vortex structure transforms into a 3D vortex structure

Effect of size reduction on the ferromagnetism of the manganite La1-xCaxMnO3 (x = 0.33)

In this paper we report an investigation on the ferromagnetic state and the nature of ferromagnetic transition of nanoparticles of $\mathrm{La_{0.67}Ca_{0.33}MnO_3}$ using magnetic measurements and neutron diffraction. The investigation was made on nanoparticles with crystal size down to $15$ nm. The neutron data show that even down to a size of $15$ nm the nanoparticles show finite spontaneous magnetization ($M_S$) although the value is much reduced compared to the bulk sample. We observed a non-monotonic variation of the ferromagnetic to paramagnetic transition temperature $T_C$ with size $d$ and found that $T_C$ initially enhances on size reduction, but for $d < 50$ nm it decreases again. The initial enhancement in $T_C$ was related to an increase in the bandwidth that occured due to a compaction of the Mn-O bond length and a straightening of the Mn-O-Mn bond angle, as determined form the neutron data. The size reduction also changes the nature of the ferromagnetic to paramagnetic transition from first order to second order with critical exponents approaching mean field values. This was explained as arising from a truncation of the coherence length by the finite sample size.Comment: 12 figure

Scaling of the Equilibrium Magnetization in the Mixed State of Type-II Superconductors

We discuss the analysis of mixed-state magnetization data of type-II superconductors using a recently developed scaling procedure. It is based on the fact that, if the Ginzburg-Landau parameter kappa does not depend on temperature, the magnetic susceptibility is a universal function of H/H_c2(T), leading to a simple relation between magnetizations at different temperatures. Although this scaling procedure does not provide absolute values of the upper critical fieldH_c2(T), its temperature variation can be established rather accurately. This provides an opportunity to validate theoretical models that are usually employed for the evaluation of H_c2(T) from equilibrium magnetization data. In the second part of the paper we apply this scaling procedure for a discussion of the notorious first order phase transition in the mixed state of high temperature superconductors. Our analysis, based on experimental magnetization data available in the literature, shows that the shift of the magnetization accross the transition may adopt either sign, depending on the particular chosen sample. We argue that this observation is inconsistent with the interpretation that this transition always represents the melting transition of the vortex lattice.Comment: 18 pages, 12 figure

Do health education initiatives assist socioeconomically disadvantaged populations? : a systematic review and meta-analyses

Background: Health education interventions are considered critical for the prevention and management of conditions of public health concern. Although the burden of these conditions is often greatest in socio-economically disadvantaged populations, the effectiveness of interventions that target these groups is unknown. We aimed to identify and synthesize evidence of the effectiveness of health-related educational interventions in adult disadvantaged populations. Methods: We pre-registered the study on Open Science Framework https://osf.io/ek5yg/. We searched Medline, Embase, Emcare, and the Cochrane Register from inception to 5/04/2022 to identify studies evaluating the effectiveness of health-related educational interventions delivered to adults in socio-economically disadvantaged populations. Our primary outcome was health related behaviour and our secondary outcome was a relevant biomarker. Two reviewers screened studies, extracted data and evaluated risk of bias. Our synthesis strategy involved random-effects meta-analyses and vote-counting. Results: We identified 8618 unique records, 96 met our criteria for inclusion – involving more than 57,000 participants from 22 countries. All studies had high or unclear risk of bias. For our primary outcome of behaviour, meta-analyses found a standardised mean effect of education on physical activity of 0.05 (95% confidence interval (CI) = -0.09–0.19), (5 studies, n = 1330) and on cancer screening of 0.29 (95% CI = 0.05–0.52), (5 studies, n = 2388). Considerable statistical heterogeneity was present. Sixty-seven of 81 studies with behavioural outcomes had point estimates favouring the intervention (83% (95% CI = 73%-90%), p < 0.001); 21 of 28 studies with biomarker outcomes showed benefit (75% (95%CI = 56%-88%), p = 0.002). When effectiveness was determined based on conclusions in the included studies, 47% of interventions were effective on behavioural outcomes, and 27% on biomarkers. Conclusions: Evidence does not demonstrate consistent, positive impacts of educational interventions on health behaviours or biomarkers in socio-economically disadvantaged populations. Continued investment in targeted approaches, coinciding with development of greater understanding of factors determining successful implementation and evaluation, are important to reduce inequalities in health